Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (41)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kienzle, G.
Right arrow Articles by von Kempis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kienzle, G.
Right arrow Articles by von Kempis, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 12, No. 1, 73-82, January 2000
© 2000 Japanese Society for Immunology

CD137 (ILA/4-1BB), expressed by primary human monocytes, induces monocyte activation and apoptosis of B lymphocytes

Georg Kienzle1,2 and Johannes von Kempis1

1 Division of Rheumatology and Clinical Immunology, University Hospital Department of Medicine, Hugstetter Strasse 55, 79106 Freiburg, Germany
2 Department of Biology, University of Freiburg, Schaentzlestrasse 1, 79104 Freiburg, Germany

Correspondence to: J. von Kempis

Human CD137 is a member of the tumor necrosis factor (TNF) receptor family and the homologue of murine 4-1BB. Recent studies have demonstrated that CD137 promotes accessory T cell activation, and regulates proliferation and survival of T lymphocytes. This study reports on the expression and function of CD137 in peripheral blood monocytes. While monocytes showed constitutive expression in 10 out of 18 healthy donors, CD137 was not expressed on resting T or B lymphocytes. Immobilized antibodies to CD137 markedly induced the production of IL-8 and TNF-{alpha} protein and mRNA, and led to inhibition of IL-10 expression by primary monocytes. Furthermore, cross-linking of CD137 on monocytes resulted in an increase of B lymphocyte apoptosis mediated by direct cell–cell contact of both cell populations. In conclusion, this study identified CD137 as a new receptor involved in monocyte activation by inducing a characteristic cytokine release profile. In addition, CD137 may play a role in monocyte-dependent control of B lymphocyte survival.

Keywords: apoptosis, cellular activation, human, inflammatory mediators, monocytes/macrophages

Transmitting editor: K. Eichmann,


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
S. Ju, S. Ju, Y. Ge, H. Qiu, B. Lu, Y. Qiu, J. Fu, G. Liu, Q. Wang, Y. Hu, et al.
A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling
Int. Immunol., October 1, 2009; 21(10): 1135 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S.-C. Lee, S.-A Ju, B.-H. Sung, S.-K. Heo, H. R. Cho, E. A. Lee, J. D. Kim, I. H. Lee, S.-M. Park, Q. T. Nguyen, et al.
Stimulation of the Molecule 4-1BB Enhances Host Defense against Listeria monocytogenes Infection in Mice by Inducing Rapid Infiltration and Activation of Neutrophils and Monocytes
Infect. Immun., May 1, 2009; 77(5): 2168 - 2176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. S. Vinay, J. D. Kim, and B. S. Kwon
Amelioration of Mercury-Induced Autoimmunity by 4-1BB
J. Immunol., October 15, 2006; 177(8): 5708 - 5717.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Zhang, K. L. Knutson, K. E. Hellstrom, M. L. Disis, and I. Hellstrom
Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion
Mol. Cancer Ther., January 1, 2006; 5(1): 149 - 155.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H. Schwarz
Biological activities of reverse signal transduction through CD137 ligand
J. Leukoc. Biol., March 1, 2005; 77(3): 281 - 286.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Wen, J. Bukczynski, and T. H. Watts
4-1BB Ligand-Mediated Costimulation of Human T Cells Induces CD4 and CD8 T Cell Expansion, Cytokine Production, and the Development of Cytolytic Effector Function
J. Immunol., May 15, 2002; 168(10): 4897 - 4906.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. A. Wilcox, A. I. Chapoval, K. S. Gorski, M. Otsuji, T. Shin, D. B. Flies, K. Tamada, R. S. Mittler, H. Tsuchiya, D. M. Pardoll, et al.
Expression of Functional CD137 Receptor by Dendritic Cells
J. Immunol., May 1, 2002; 168(9): 4262 - 4267.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Futagawa, H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and K. Okumura
Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells
Int. Immunol., March 1, 2002; 14(3): 275 - 286.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Zhu, D. B. Flies, K. Tamada, Y. Sun, M. Rodriguez, Y.-X. Fu, and L. Chen
Progressive Depletion of Peripheral B Lymphocytes in 4-1BB (CD137) Ligand/I-E{alpha}-Transgenic Mice
J. Immunol., September 1, 2001; 167(5): 2671 - 2676.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.